Prasanth R. Nyalapatla

708 citations

17 papers · 449 indexed · h-index 11

Virology top 5%
- HIV Research and Treatment 8
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 9
- Viral gastroenteritis research and epidemiology 2
- HIV/AIDS Research and Interventions 2
Organic Chemistry
- Click Chemistry and Applications 3
- Chemical synthesis and alkaloids 2
- Synthetic Organic Chemistry Methods 2
Computational Theory and Mathematics top 10%
Animal Science and Zoology
Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment 5

Co-authors: Arun K. Ghosh Heather L. Osswald Hiroaki Mitsuya Manabu Aoki Kalapala Venkateswara Rao Irene T. Weber Johnson Agniswamy Andrew D. Mesecar
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Journal of Medicinal Chemistry (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Scientific Reports (1 paper)
Partner nations: United States Japan France

In The Last Decade

Prasanth R. Nyalapatla

17 papers receiving 440 citations

Peers

Countries citing papers authored by Prasanth R. Nyalapatla

Since Specialization

Citations

This map shows the geographic impact of Prasanth R. Nyalapatla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasanth R. Nyalapatla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasanth R. Nyalapatla more than expected).

Fields of papers citing papers by Prasanth R. Nyalapatla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasanth R. Nyalapatla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasanth R. Nyalapatla. The network helps show where Prasanth R. Nyalapatla may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Prasanth R. Nyalapatla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Prasanth R. Nyalapatla Line = papers co-authored together Prasanth R. Nyalapatla links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	OGG1 and MUTYH repair activities promote telomeric 8-oxoguanine induced senescence in human fibroblasts Nature Communications ·栾丽,Ryan Barnes,Aliyu Nasir Kankara,Prasanth R. Nyalapatla,Peter Wipf,Patricia L. Opresko	2025	5
2	Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity Scientific Reports ·Haydar Bulut,Shin‐ichiro Hattori,Wendell Xavier Santana da Silva,Hironori Hayashi,Debananda Das,Manabu Aoki,David A. Davis,Kalapala Venkateswara Rao,Prasanth R. Nyalapatla,Arun K. Ghosh,Hiroaki Mitsuya	2020	70
3	Fluorescent Probes for Monitoring Serine Ubiquitination Biochemistry ·Kedar Puvar,Adistia Dian,Joshua Glasser,Yiyang Zhou,Prasanth R. Nyalapatla,Jiaqi Fu,Alexander R. Rovira,Yitzhak Tor,Zhao‐Qing Luo,Arun K. Ghosh,Mary J. Wirth,Jean Chmielewski,Tamara L. Kinzer‐Ursem,Chittaranjan Das	2020	7
4	Co(II)‐salen catalyzed stereoselective cyclopropanation of fluorinated styrenes Chirality ·Salisu Yusuf Muhammad,Dayang Zhong,Prasanth R. Nyalapatla,Peter Wipf	2019	4
5	Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants Antimicrobial Agents and Chemotherapy ·Shin‐ichiro Hattori,Hironori Hayashi,Haydar Bulut,Kalapala Venkateswara Rao,Prasanth R. Nyalapatla,Kazuya Hasegawa,Manabu Aoki,Arun K. Ghosh,Hiroaki Mitsuya	2019	10
6	Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure–Activity Studies, Biological and X-ray Structural Analysis Journal of Medicinal Chemistry ·Arun K. Ghosh,Prasanth R. Nyalapatla,Burak Hızlı,Kalapala Venkateswara Rao,Margherita Brindisi,Heather L. Osswald,Masayuki Amano,Manabu Aoki,Johnson Agniswamy,Yuan‐Fang Wang,Irene T. Weber,Hiroaki Mitsuya	2018	32
7	A New Synthesis of Gefitinib Synlett ·Dayang Zhong,Lega’ K. Strain,Matthew G. LaPorte,Prasanth R. Nyalapatla,Peter Wipf	2018	6
8	Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants ChemMedChem ·Arun K. Ghosh,Kalapala Venkateswara Rao,Prasanth R. Nyalapatla,Burak Hızlı,Margherita Brindisi,Heather L. Osswald,Bhavanam Sekhara Reddy,Johnson Agniswamy,Yuan‐Fang Wang,Manabu Aoki,Shin‐ichiro Hattori,Irene T. Weber,Hiroaki Mitsuya	2018	33
9	Total syntheses of both enantiomers of amphirionin 4: A chemoenzymatic based strategy for functionalized tetrahydrofurans Tetrahedron ·Arun K. Ghosh,Prasanth R. Nyalapatla	2017	7
10	Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex Bioorganic & Medicinal Chemistry ·Arun K. Ghosh,Margherita Brindisi,Prasanth R. Nyalapatla,Jun Takayama,Delfina Díaz,S Maekawa,Johnson Agniswamy,Yuan-Fang Wang,Manabu Aoki,Masayuki Amano,Irene T. Weber,Hiroaki Mitsuya	2017	14
11	Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants Journal of Medicinal Chemistry ·Arun K. Ghosh,Kalapala Venkateswara Rao,Prasanth R. Nyalapatla,Heather L. Osswald,Xiang Chensheng,Manabu Aoki,Hironori Hayashi,Johnson Agniswamy,Yuan-Fang Wang,Haydar Bulut,Debananda Das,Irene T. Weber,Hiroaki Mitsuya	2017	62
12	Enantioselective Total Synthesis of (+)-Amphirionin-4 Organic Letters ·Arun K. Ghosh,Prasanth R. Nyalapatla	2016	13
13	Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro) Journal of Biological Chemistry ·Sakshi Tomar,Melanie L. Johnston,Sarah E. St. John,Heather L. Osswald,Prasanth R. Nyalapatla,Lake N. Paul,Arun K. Ghosh,Mark R. Denison,Andrew D. Mesecar	2015	111
14	X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design Bioorganic & Medicinal Chemistry Letters ·Sarah E. St. John,B. Keith Putt,Prasanth R. Nyalapatla,Heather L. Osswald,Arun K. Ghosh,Andrew D. Mesecar	2015	16
15	A Novel Tricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor, GRL-0739, Effectively Inhibits the Replication of Multidrug-Resistant HIV-1 Variants and Has a Desirable Central Nervous System Penetration Property In Vitro Antimicrobial Agents and Chemotherapy ·Masayuki Amano,Yasushi Tojo,B Tuckerman David,Georg Ernst,Prasanth R. Nyalapatla,Debananda Das,Arun K. Ghosh,Hiroaki Mitsuya	2015	9
16	Design, synthesis, biological evaluation and X-ray structural studies of HIV-1 protease inhibitors containing substituted fused-tetrahydropyranyl tetrahydrofuran as P2-ligands Organic & Biomolecular Chemistry ·Arun K. Ghosh,Xiang Chensheng,MP Thelen,Prasanth R. Nyalapatla,Iestyn Hartbrich,Johnson Agniswamy,Yuan-Fang Wang,Irene T. Weber,Masayuki Amano,Hiroaki Mitsuya	2015	10
17	Highly Potent HIV-1 Protease Inhibitors with Novel Tricyclic P2 Ligands: Design, Synthesis, and Protein–Ligand X-ray Studies Journal of Medicinal Chemistry ·Arun K. Ghosh,Georg Ernst,Xiang Chensheng,Prasanth R. Nyalapatla,Heather L. Osswald,Johnson Agniswamy,Yuan-Fang Wang,Masayuki Amano,Irene T. Weber,Hiroaki Mitsuya	2013	40

About Prasanth R. Nyalapatla

Prasanth R. Nyalapatla is a scholar working on Virology, Infectious Diseases, Organic Chemistry, Endocrinology and Epidemiology, having authored 17 papers that have together received 449 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Click Chemistry and Applications (3 papers), Viral gastroenteritis research and epidemiology (2 papers), HIV/AIDS Research and Interventions (2 papers), Chemical synthesis and alkaloids (2 papers) and Synthetic Organic Chemistry Methods (2 papers). The work is most often cited by research in Virology (120 citations), Infectious Diseases (254 citations), Organic Chemistry (136 citations), Computational Theory and Mathematics (64 citations) and Animal Science and Zoology (35 citations). Prasanth R. Nyalapatla has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Arun K. Ghosh, Heather L. Osswald, Hiroaki Mitsuya, Manabu Aoki, Kalapala Venkateswara Rao, Irene T. Weber, Johnson Agniswamy, Andrew D. Mesecar, Sarah E. St. John and Debananda Das. Their work appears in journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Scientific Reports, Organic Letters and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact